Press Releases for ARNA

Press Releases
PicksThatMove.Com Announces Investment Opinion on ARNA, MRVL, VVUS, NET and TSM
3 new diet pills race to hit market
BioMed Realty Trust Commemorates Five-Year Anniversary As a Public Company ; Ringing NYSE Closing Bell(R) Today; Provides Tenant Update
Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments
Arena Pharmaceuticals to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, August 3, 2009
StockPreacher.com Issues Trading Outlook for Orexigen Therapeutics Inc.
Arena Pharmaceuticals Announces Public Offering of Common Stock
InvestorSoup.com Researches Wall Street Movers: Antigenics, Arena Pharma, Liz Claiborne, Powerwave Tech, Avis Budget Group, Unisys
Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference
Arena Pharmaceuticals to Receive $100 Million from Deerfield Management
Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
Arena Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference
Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Association's 69th Scientific Sessions
Arena Pharmaceuticals to Present at the 34th Annual Deutsche Bank Health Care Conference
Arena Pharmaceuticals Announces First Quarter 2009 Financial Results
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, May 11, 2009
BioMed Realty Trust Reports First Quarter 2009 Operating and Financial Results
Beacon Equity Issues Trade Alerts on Market Movers: CAH, LEAP, FISV, PBG, ARNA, LEN
Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints
Arena Pharmaceuticals to Host Conference Call and Webcast on Monday, March 30, 2009 to Discuss Lorcaserin Pivotal Phase 3 Obesity Trial Results
Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results
Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009
Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
Zacks Analyst Blog Highlights: Arena Pharmaceuticals, Inc., FactSet Research Systems Inc., UST Inc., Altria Group and Joy Global Inc.
Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference
Zacks Analyst Blog Highlights: Lan Airlines S.A., Sierra Wireless Inc., Grey Wolf, Inc., Precision Drilling Trust and Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008
Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
Arena Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
BeaconEquity.com Issues TraderNotes on Active Stocks: SWHC, ARNA, BORL, QTWW, CSGH, FEED, BVN, CEGE
Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
Arena Pharmaceuticals to Present at Citigroup's Global Healthcare Conference - May 27 2008 12:56AM
Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference - Jun 1 2008 7:16AM
New Analyst Reports for REAL GOODS SOLAR INC, HOLOGIC INC, ARENA PHARMACEUTICALS INC, and BIOCRYST PHARMACEUTICALS INC - May 27 2008 1:17AM
Arena Pharmaceuticals Announces First Quarter 2008 Financial Results - Jun 1 2008 7:16AM
Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. - Jun 1 2008 7:15AM
Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia